206 related articles for article (PubMed ID: 11063750)
1. Role of the C-terminal G3 domain in sorting and secretion of aggrecan core protein and ubiquitin-mediated degradation of accumulated mutant precursors.
Domowicz MS; Pirok EW; Novak TE; Schwartz NB
J Biol Chem; 2000 Nov; 275(45):35098-105. PubMed ID: 11063750
[TBL] [Abstract][Full Text] [Related]
2. Aggrecan domains expected to traffic through the exocytic pathway are misdirected to the nucleus.
Chen TL; Wang PY; Luo W; Gwon SS; Flay NW; Zheng J; Guo C; Tanzer ML; Vertel BM
Exp Cell Res; 2001 Feb; 263(2):224-35. PubMed ID: 11161721
[TBL] [Abstract][Full Text] [Related]
3. Nanomelic chondrocytes synthesize, but fail to translocate, a truncated aggrecan precursor.
Vertel BM; Walters LM; Grier B; Maine N; Goetinck PF
J Cell Sci; 1993 Mar; 104 ( Pt 3)():939-48. PubMed ID: 8314884
[TBL] [Abstract][Full Text] [Related]
4. The folded modules of aggrecan G3 domain exert two separable functions in glycosaminoglycan modification and product secretion.
Chen L; Wu Y; Lee V; Kiani C; Adams ME; Yao Y; Yang BB
J Biol Chem; 2002 Jan; 277(4):2657-65. PubMed ID: 11714693
[TBL] [Abstract][Full Text] [Related]
5. The folded protein modules of the C-terminal G3 domain of aggrecan can each facilitate the translocation and secretion of the extended chondroitin sulfate attachment sequence.
Day JM; Murdoch AD; Hardingham TE
J Biol Chem; 1999 Dec; 274(53):38107-11. PubMed ID: 10608880
[TBL] [Abstract][Full Text] [Related]
6. Non-glycosaminoglycan bearing domains of perlecan and aggrecan influence the utilization of sites for heparan and chondroitin sulfate synthesis.
Doege K; Chen X; Cornuet PK; Hassell J
Matrix Biol; 1997 Oct; 16(4):211-21. PubMed ID: 9402011
[TBL] [Abstract][Full Text] [Related]
7. Aggrecan synthesis and secretion. A paradigm for molecular and cellular coordination of multiglobular protein folding and intracellular trafficking.
Zheng J; Luo W; Tanzer ML
J Biol Chem; 1998 May; 273(21):12999-3006. PubMed ID: 9582335
[TBL] [Abstract][Full Text] [Related]
8. Selective intracellular retention of extracellular matrix proteins and chaperones associated with pseudoachondroplasia.
Vranka J; Mokashi A; Keene DR; Tufa S; Corson G; Sussman M; Horton WA; Maddox K; Sakai L; Bächinger HP
Matrix Biol; 2001 Nov; 20(7):439-50. PubMed ID: 11691584
[TBL] [Abstract][Full Text] [Related]
9. Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera.
García-Mata R; Bebök Z; Sorscher EJ; Sztul ES
J Cell Biol; 1999 Sep; 146(6):1239-54. PubMed ID: 10491388
[TBL] [Abstract][Full Text] [Related]
10. Organizational diversity among distinct glycoprotein endoplasmic reticulum-associated degradation programs.
Cabral CM; Liu Y; Moremen KW; Sifers RN
Mol Biol Cell; 2002 Aug; 13(8):2639-50. PubMed ID: 12181335
[TBL] [Abstract][Full Text] [Related]
11. A novel quality control compartment derived from the endoplasmic reticulum.
Kamhi-Nesher S; Shenkman M; Tolchinsky S; Fromm SV; Ehrlich R; Lederkremer GZ
Mol Biol Cell; 2001 Jun; 12(6):1711-23. PubMed ID: 11408579
[TBL] [Abstract][Full Text] [Related]
12. ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway.
Hiller MM; Finger A; Schweiger M; Wolf DH
Science; 1996 Sep; 273(5282):1725-8. PubMed ID: 8781238
[TBL] [Abstract][Full Text] [Related]
13. The chondrodystrophy, nanomelia: biosynthesis and processing of the defective aggrecan precursor.
Vertel BM; Grier BL; Li H; Schwartz NB
Biochem J; 1994 Jul; 301 ( Pt 1)(Pt 1):211-6. PubMed ID: 8037674
[TBL] [Abstract][Full Text] [Related]
14. The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1.
Sandy JD; Thompson V; Doege K; Verscharen C
Biochem J; 2000 Oct; 351(Pt 1):161-6. PubMed ID: 10998358
[TBL] [Abstract][Full Text] [Related]
15. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.
Schubert U; Antón LC; Bacík I; Cox JH; Bour S; Bennink JR; Orlowski M; Strebel K; Yewdell JW
J Virol; 1998 Mar; 72(3):2280-8. PubMed ID: 9499087
[TBL] [Abstract][Full Text] [Related]
16. Divergent secretory behavior of the opposite ends of aggrecan.
Luo W; Kuwada TS; Chandrasekaran L; Zheng J; Tanzer ML
J Biol Chem; 1996 Jul; 271(28):16447-50. PubMed ID: 8663569
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitination is required for the retro-translocation of a short-lived luminal endoplasmic reticulum glycoprotein to the cytosol for degradation by the proteasome.
de Virgilio M; Weninger H; Ivessa NE
J Biol Chem; 1998 Apr; 273(16):9734-43. PubMed ID: 9545309
[TBL] [Abstract][Full Text] [Related]
18. Maturation of lipoprotein lipase in the endoplasmic reticulum. Concurrent formation of functional dimers and inactive aggregates.
Ben-Zeev O; Mao HZ; Doolittle MH
J Biol Chem; 2002 Mar; 277(12):10727-38. PubMed ID: 11796709
[TBL] [Abstract][Full Text] [Related]
19. Developmental expression of the HNK-1 carbohydrate epitope on aggrecan during chondrogenesis.
Domowicz MS; Mueller MM; Novak TE; Schwartz LE; Schwartz NB
Dev Dyn; 2003 Jan; 226(1):42-50. PubMed ID: 12508223
[TBL] [Abstract][Full Text] [Related]
20. Degradation of aggrecan precursors within a specialized subcompartment of the chicken chondrocyte endoplasmic reticulum.
Alonso M; Hidalgo J; Hendricks L; Velasco A
Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):487-95. PubMed ID: 8687392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
